A new GLP-1 supply tracker is online that can help find Ozempic near you while also providing supply chain and shortage data to the U.S. Food and Drug Administration (FDA).
Telehealth startup Ro has launched this new GLP-1 supply tracker on its website. It includes a map of the United States that shows which states are currently reporting shortages of weight-loss drugs.
The GLP-1 supply tracker covers Ozempic and other weight-loss drugs. Among them are Wegovy, Mounjaro, Zepbound, Saxenda and Victoza. The map also shows patients where others are having luck finding these treatments.
New GLP-1 Supply Tracker Updates
In addition to this, users of the website can sign up for notices. That includes getting alerts for when one of the weight-loss drugs listed is no longer in short supply. Healthcare providers can also use the GLP-1 supply tracker to report shortages or supplies being in stock.
Ro CEO Zachariah Reitano said the following about the need for a GLP-1 supply tracker to Fortune:
“The GLP-1 shortage challenges are exacerbated by a lack of accurate, up-to-date, and accessible GLP-1 supply information. Patients deserve better.”
Investors will want to stick around for breakdowns of all the hottest stock market stories on Thursday.
We have all of the biggest stock market news that traders need to know about today! Among that is what has shares of Momentus (NASDAQ:MNTS), Palantir (NYSE:PLTR) and Apple (NASDAQ:AAPL) stock moving today. All of that info is ready to go at the links below!
More Thursday Stock Market News
- Momentus (MNTS) Stock Blasts Off on New DARPA Deal
- PLTR Stock Alert: Palantir Bags Pentagon Contract for Maven AI
- iPhone 7 Settlement: Your Deadline to File a Class-Action Lawsuit Claim Is June 3
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
